Eargo Inc
NASDAQ:EAR
Eargo Inc
Cash from Investing Activities
Eargo Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eargo Inc
NASDAQ:EAR
|
Cash from Investing Activities
-$3.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-114%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Eargo Inc's Cash from Investing Activities?
Cash from Investing Activities
-3.1m
USD
Based on the financial report for Dec 31, 2022, Eargo Inc's Cash from Investing Activities amounts to -3.1m USD.
What is Eargo Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-53%
Over the last year, the Cash from Investing Activities growth was 59%. The average annual Cash from Investing Activities growth rates for Eargo Inc have been 7% over the past three years , -53% over the past five years .